On Friday, Sanofi ADR (NASDAQ: SNY) opened higher 0.35% from the last session, before settling in for the closing price of $54.15. Price fluctuations for SNY have ranged from $45.22 to $58.97 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.99%. Company’s average yearly earnings per share was noted 15.49% at the time writing. With a float of $2.50 billion, this company’s outstanding shares have now reached $2.61 billion.
Let’s determine the extent of company efficiency that accounts for 87994 employees. In terms of profitability, gross margin is 67.89%, operating margin of 21.72%, and the pretax margin is 15.36%.
Sanofi ADR (SNY) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Sanofi ADR is 0.00%, while institutional ownership is 11.26%.
Sanofi ADR (SNY) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 15.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.40% during the next five years compared to 13.78% growth over the previous five years of trading.
Sanofi ADR (NASDAQ: SNY) Trading Performance Indicators
Check out the current performance indicators for Sanofi ADR (SNY). In the past quarter, the stock posted a quick ratio of 0.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.05. Likewise, its price to free cash flow for the trailing twelve months is 23.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.81, a number that is poised to hit 0.84 in the next quarter and is forecasted to reach 4.76 in one year’s time.
Technical Analysis of Sanofi ADR (SNY)
Looking closely at Sanofi ADR (NASDAQ: SNY), its last 5-days average volume was 3.25 million, which is a jump from its year-to-date volume of 2.7 million. As of the previous 9 days, the stock’s Stochastic %D was 76.05%. Additionally, its Average True Range was 0.99.
During the past 100 days, Sanofi ADR’s (SNY) raw stochastic average was set at 66.15%, which indicates a significant decrease from 92.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.85% in the past 14 days, which was lower than the 22.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $49.14, while its 200-day Moving Average is $51.22. However, in the short run, Sanofi ADR’s stock first resistance to watch stands at $54.52. Second resistance stands at $54.70. The third major resistance level sits at $55.05. If the price goes on to break the first support level at $53.98, it is likely to go to the next support level at $53.63. Now, if the price goes above the second support level, the third support stands at $53.45.
Sanofi ADR (NASDAQ: SNY) Key Stats
There are currently 2,537,845K shares outstanding in the company with a market cap of 135.61 billion. Presently, the company’s annual sales total 50,266 M according to its annual income of 5,844 M. Last quarter, the company’s sales amounted to 15,567 M and its income totaled 3,095 M.
